Immune-based Therapy Clinical Trials in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality and continues to increase. Current standard of care for patients with HCC only provides limited therapeutic benefit. Development of innovative strategies is urgently needed. Experience with immunotherapy in HCC is...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Dai, Staveley-O’Carroll, Kevin F., Li, Guangfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750497/
https://www.ncbi.nlm.nih.gov/pubmed/26877890
http://dx.doi.org/10.4172/2155-9899.1000376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750497/
https://www.ncbi.nlm.nih.gov/pubmed/26877890
http://dx.doi.org/10.4172/2155-9899.1000376

Ejemplares similares